From Europe. For the global patent community.
Trending Topics:
JUVE Patent Pharmaceuticals

Pharmaceuticals

Cases
Supplementary protection certificates

Astellas defends use patent and SPC with Hoffmann Eitle

Astellas has successfully defended an important patent and SPC for the treatment of an overactive bladder. The Federal Court of Justice has now upheld ...

26 July 2024 by Konstanze Richter
Cases
Supplementary protection certificates

Italian Supreme Court rules on Bolar exemption in Boehringer Ingelheim dispute

Pharmaceutical substance manufacturer Sicor has infringed a patent held by Boehringer Ingelheim and must now pay damages. The Supreme Court also clari ...

23 July 2024 by Mathieu Klos
Cases
Unified Patent Court

Sanofi and Regeneron overturn key Amgen patent at UPC

The first main attack on a patent at the UPC has been successful. The Munich central division has overturned an important patent belonging to Amgen fo ...

16 July 2024 by Mathieu Klos
People & Business
France

Reed Smith patent team joins Gowling WLG

Marianne Schaffner has moved to Gowling WLG with two associates. After working at US law firms such as Reed Smith, she is now returning to a patent te ...

27 June 2024 by Mathieu Klos
Cases
Long read

Race for first substantial UPC judgment — why July will be decisive

Following a good start, patent experts are now waiting for the court's first substantial judgments in infringement and revocation proceedings. With fo ...

20 June 2024 by Mathieu Klos
Cases
Blockbuster drug

Munich Regional Court sticks to its guns in PI dispute over Bayer's Xarelto

The PIs preventing Accord, betapharm, 089 Pharm and Zentiva from selling generic rivaroxaban products in Germany remain in place. Munich Regional Cour ...

18 June 2024 by Mathieu Klos
Cases
Combination drug SPCs

Advocate General points the way to interpretation of SPC regulation

For over a year, the patent market has awaited the European Court of Justice's decision on the interpretation of the SPC regulation. An opinion from t ...

14 June 2024 by Konstanze Richter
People & Business
UK

Shoosmiths hires patent litigator specialising in life sciences

As part of a strategy to build up its IP areas of technology, life sciences and brands by 2030, UK firm Shoosmiths has hired patent litigation partner ...

17 May 2024 by Laura King
Cases
Case preview

A&O Shearman's first UK patent outing for Bayer in Xarelto appeal

Today, the UK Court of Appeal will hear Bayer's appeal against a first-instance finding of invalidity, which the high court handed down in April. With ...

16 May 2024 by Amy Sandys
People & Business
Ireland

Taylor Wessing strengthens Irish offering with first patent-specialist partner

International firm Taylor Wessing has shored up its patent expertise in Dublin with the appointment of patent litigator Eoin Martyn. He joins the firm ...

15 May 2024 by Amy Sandys
Cases
Biotechnology

ACD and Molecular Instruments take RNA-sequencing patent battle to the UPC

The UK High Court has found two Advanced Cell Diagnostics patents invalid for obviousness, with the company now filing an infringement case against Mo ...

7 May 2024 by Amy Sandys
Cases
Blockbuster drug

UK courts revoke Bayer rivaroxaban patent in new win for generics

Mutiple pharmaceutical companies have succeeded in revoking a blockbuster Bayer patent in the latest round of proceedings, which have this time taken ...

19 April 2024 by Amy Sandys
Cases
Blockbuster drug

Why Bayer is fighting so hard for Xarelto

The need for German pharmaceutical company Bayer to restructure is discussed almost daily in the press. In these reports, the name of one blockbuster ...

2 April 2024 by Christina Schulze
Cases
Pharmaceuticals

Xarelto battle reaches Sweden with Bayer win against Sandoz

Bayer has won an important victory at the Stockholm Patent and Market Court in Sweden after the court confirmed a patent for blockbuster drug, Xarelto ...

5 March 2024 by Mathieu Klos
Cases
Pharmaceuticals

Akebia defends anaemia drug patents at EPO amid huge Fibrogen battle

Akebia Therapeutics has successfully defended two patents integral to a drug used to treat anaemia resulting from chronic kidney disease. The result i ...

1 March 2024 by Amy Sandys
Popular